95 related articles for article (PubMed ID: 22295566)
1. [Pharmacogenomics of multiple sclerosis: association of immune response genes polymorphism with copaxone treatment efficacy].
Tsareva EIu; Kulakova OG; Makarycheva OIu; Boĭko AN; Shchur SG; Lashch NIu; Popova NF; Gusev EI; Bashinskaia VV; L'vov DV; Favorov AV; Ochs MF; Favorova OO
Mol Biol (Mosk); 2011; 45(6):963-72. PubMed ID: 22295566
[TBL] [Abstract][Full Text] [Related]
2. Allelic combinations of immune-response genes associated with glatiramer acetate treatment response in Russian multiple sclerosis patients.
Tsareva EY; Kulakova OG; Boyko AN; Shchur SG; Lvovs D; Favorov AV; Gusev EI; Vandenbroeck K; Favorova OO
Pharmacogenomics; 2012 Jan; 13(1):43-53. PubMed ID: 22111603
[TBL] [Abstract][Full Text] [Related]
3. Allelic combinations of immune-response genes as possible composite markers of IFN-β efficacy in multiple sclerosis patients.
Kulakova OG; Tsareva EY; Boyko AN; Shchur SG; Gusev EI; Lvovs D; Favorov AV; Vandenbroeck K; Favorova OO
Pharmacogenomics; 2012 Nov; 13(15):1689-700. PubMed ID: 23171334
[TBL] [Abstract][Full Text] [Related]
4. Comparative pharmacogenetics of multiple sclerosis: IFN-β versus glatiramer acetate.
Kulakova OG; Tsareva EY; Lvovs D; Favorov AV; Boyko AN; Favorova OO
Pharmacogenomics; 2014 Apr; 15(5):679-85. PubMed ID: 24798724
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of linkage and association of alleles of proinflammatory cytokines genes IL-6, IFNg and TNF with multiple sclerosis using transmission disequilibrium test (TDT)].
Makarycheva OIu; Tsareva EIu; Sudomoina MA; Kulakova OG; Bykova OV; Gol'tsova NV; Kuzenkova LM; Boĭko AN; Favorova OO
Mol Biol (Mosk); 2010; 44(5):824-30. PubMed ID: 21090238
[TBL] [Abstract][Full Text] [Related]
6. Cytokine gene polymorphisms and genetic association with coeliac disease in the Finnish population.
Woolley N; Mustalahti K; Mäki M; Partanen J
Scand J Immunol; 2005 Jan; 61(1):51-6. PubMed ID: 15644122
[TBL] [Abstract][Full Text] [Related]
7. Effect of immunomodulatory treatment of multiple sclerosis on lymphocyte surface immunomarkers.
Michałowska-Wender G; Losy J; Wender M; Januszkiewicz-Lewandowska D; Nowak J
Pol J Pharmacol; 2003; 55(5):877-80. PubMed ID: 14704481
[TBL] [Abstract][Full Text] [Related]
8. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
Bongioanni P; Romano MR; Boccardi B; Lombardo F; Moscato G; Mosti S; Baldini C; Nuti S; Meucci G; Rossi B
Rev Neurol; 1999 Nov 16-30; 29(10):893-9. PubMed ID: 10637835
[TBL] [Abstract][Full Text] [Related]
9. Interaction of HLA-DRB1*1501 allele and TNF-alpha -308 G/A single nucleotide polymorphism in the susceptibility to multiple sclerosis.
Shahbazi M; Roshandel D; Omidnyia E; Rshaidbaghan A
Clin Immunol; 2011 Jun; 139(3):277-81. PubMed ID: 21396892
[TBL] [Abstract][Full Text] [Related]
10. Association and interaction of the TNF-alpha gene with other pro- and anti-inflammatory cytokine genes and HLA genes in patients with type 1 diabetes from North India.
Kumar R; Goswami R; Agarwal S; Israni N; Singh SK; Rani R
Tissue Antigens; 2007 Jun; 69(6):557-67. PubMed ID: 17498265
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of glatiramer acetate therapy for multiple sclerosis reveals drug-response markers.
Grossman I; Avidan N; Singer C; Goldstaub D; Hayardeny L; Eyal E; Ben-Asher E; Paperna T; Pe'er I; Lancet D; Beckmann JS; Miller A
Pharmacogenet Genomics; 2007 Aug; 17(8):657-66. PubMed ID: 17622942
[TBL] [Abstract][Full Text] [Related]
12. Impact of cytokine gene polymorphisms on risk and treatment outcomes of aplastic anemia.
Lee YG; Kim I; Kim JH; Bae JY; Kwon JH; Shin DY; Lee JE; Song EY; Kim HK; Yoon SS; Park SS; Lee DS; Han KS; Park MH; Hong YC; Park S; Kim BK
Ann Hematol; 2011 May; 90(5):515-21. PubMed ID: 20953611
[TBL] [Abstract][Full Text] [Related]
13. Glatiramer acetate (Copaxone).
Francis DA
Int J Clin Pract; 2001; 55(6):394-8. PubMed ID: 11501229
[TBL] [Abstract][Full Text] [Related]
14. Three allele combinations associated with multiple sclerosis.
Favorova OO; Favorov AV; Boiko AN; Andreewski TV; Sudomoina MA; Alekseenkov AD; Kulakova OG; Gusev EI; Parmigiani G; Ochs MF
BMC Med Genet; 2006 Jul; 7():63. PubMed ID: 16872485
[TBL] [Abstract][Full Text] [Related]
15. No evidence of IL21 association with multiple sclerosis in a Swedish population.
Lindén M; Nohra R; Sundqvist E; Khademi M; Hillert J; Alfredsson L; Olsson T; Kockum I
Tissue Antigens; 2011 Oct; 78(4):271-4. PubMed ID: 21736561
[TBL] [Abstract][Full Text] [Related]
16. Distinct tumour necrosis factor alpha, interferon gamma, interleukin 10, and cytotoxic T cell antigen 4 gene polymorphisms in disease occurrence and end stage renal disease in Wegener's granulomatosis.
Spriewald BM; Witzke O; Wassmuth R; Wenzel RR; Arnold ML; Philipp T; Kalden JR
Ann Rheum Dis; 2005 Mar; 64(3):457-61. PubMed ID: 15708894
[TBL] [Abstract][Full Text] [Related]
17. [Genetic predisposition to multiple sclerosis as a polygenic autoimmune disease].
Favorova OO; Favorov AV; Boĭko AN; Sudomoina MA; Andreevskiĭ TV; Alekseenkov AD; Kulakova OG; Gusev EI; Parmigiani G; Ochs MF
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7 Suppl 2):16-22. PubMed ID: 19894308
[TBL] [Abstract][Full Text] [Related]
18. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.
Zipp F; Weber F; Huber S; Sotgiu S; Czlonkowska A; Holler E; Albert E; Weiss EH; Wekerle H; Hohlfeld R
Ann Neurol; 1995 Nov; 38(5):723-30. PubMed ID: 7486863
[TBL] [Abstract][Full Text] [Related]
19. Disease-modifying drugs for the early treatment of multiple sclerosis.
Flachenecker P
Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542
[TBL] [Abstract][Full Text] [Related]
20. [A comparative analysis of rebif 22-mcg and copaxone efficacy in multiple sclerosis].
Zavalishin IA; Peresedova AV; Stoĭda NI; Rebrova Oi; Zakharova MN; Adarcheva LS; Niazbekova AS; Askarova LSh; Baĭdina EV
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Spec No 3():111-5. PubMed ID: 17172245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
